000 01664 a2200445 4500
005 20250517034545.0
264 0 _c20151013
008 201510s 0 0 eng d
022 _a1432-0843
024 7 _a10.1007/s00280-015-2791-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChristner, Susan M
245 0 0 _aIn vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2/4-p53 interaction.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cAug 2015
300 _a287-99 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aFemale
650 0 4 _aHCT116 Cells
650 0 4 _aHeterografts
650 0 4 _aHumans
650 0 4 _aMice, SCID
650 0 4 _aNeoplasm Transplantation
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-mdm2
_xmetabolism
650 0 4 _aPyrazoles
_xchemistry
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
650 0 4 _aUbiquitin-Protein Ligases
_xmetabolism
700 1 _aClausen, Dana M
700 1 _aBeumer, Jan H
700 1 _aParise, Robert A
700 1 _aGuo, Jianxia
700 1 _aHuang, Yijun
700 1 _aDömling, Alexander S
700 1 _aEiseman, Julie L
773 0 _tCancer chemotherapy and pharmacology
_gvol. 76
_gno. 2
_gp. 287-99
856 4 0 _uhttps://doi.org/10.1007/s00280-015-2791-y
_zAvailable from publisher's website
999 _c24958458
_d24958458